TY - JOUR
KW - Alcoholism/drug therapy
KW - Analgesics, Opioid/adverse effects
KW - Female
KW - Humans
KW - Male
KW - Opioid-Related Disorders/drug therapy
AU - J. H. Ford 2nd
AU - A. J. Abraham
AU - N. Lupulescu-Mann
AU - R. Croff
AU - K. A. Hoffman
AU - K. Alanis-Hirsch
AU - M. Chalk
AU - L. Schmidt
AU - D. McCarty
A1 - 
AB - OBJECTIVE: The Medication Research Partnership (MRP), a collaboration between a national commercial health plan and nine addiction treatment centers, implemented organizational and system changes to promote use of federally approved medications for treatment of alcohol and opioid use disorders. METHOD: A difference-in-differences analysis examined change over time in the percentage of patients receiving a prescription medication for alcohol or opioid use disorders treated in MRP (n = 9) and comparison (n = 15) sites. RESULTS: MRP clinics experienced a 2.4-fold increase in patients receiving an alcohol or opioid prescription (13.2% at baseline to 31.7% at 3 years after MRP initiation); comparison clinics experienced significantly less change (17.6% to 23.5%) with an adjusted difference-in-differences of 12.5% (95% CI [5.4, 19.6], p = .001). MRP sites increased the patients with prescriptions to treat opioid use disorder from 17.0% (baseline) to 36.8% (3 years after initiation), with smaller changes observed in comparison sites (23.2% to 24.0%) and a 3-year post-initiation adjusted difference-in-differences of 19% (95% CI [8.5, 29.5], p = .000). Medications for alcohol use disorders increased in both MRP (9.0% to 26.5%) and comparison sites (11.4% to 23.1%). CONCLUSIONS: Promoting the use of medications to support recovery required complex interventions. The Advancing Recovery System Change Model, initially developed in publicly funded systems of care, was successfully adapted for commercial sector use. The model provides a framework for providers and commercial health plans to collaborate and increase patient access to medications.
AD - Center for Health Systems Research and Analysis, University of Wisconsin-Madison, Madison, Wisconsin.; Department of Public Administration and Policy, School of Public and International Affairs, University of Georgia, Athens, Georgia.; Center for Health Systems Effectiveness, Oregon Health & Science University, Portland, Oregon.; OHSU-PSU School of Public Health, Oregon Health & Science University, Portland, Oregon.; OHSU-PSU School of Public Health, Oregon Health & Science University, Portland, Oregon.; 2M Research Services, Raleigh-Durham, North Carolina.; The Chalk Group, Washington, D.C.; School of Medicine, University of California at San Francisco, San Francisco, California.; OHSU-PSU School of Public Health, Oregon Health & Science University, Portland, Oregon.
BT - Journal of studies on alcohol and drugs
C5 - Opioids & Substance Use
CP - 5
CY - United States
IS - 5
JF - Journal of studies on alcohol and drugs
M1 - Journal Article
N2 - OBJECTIVE: The Medication Research Partnership (MRP), a collaboration between a national commercial health plan and nine addiction treatment centers, implemented organizational and system changes to promote use of federally approved medications for treatment of alcohol and opioid use disorders. METHOD: A difference-in-differences analysis examined change over time in the percentage of patients receiving a prescription medication for alcohol or opioid use disorders treated in MRP (n = 9) and comparison (n = 15) sites. RESULTS: MRP clinics experienced a 2.4-fold increase in patients receiving an alcohol or opioid prescription (13.2% at baseline to 31.7% at 3 years after MRP initiation); comparison clinics experienced significantly less change (17.6% to 23.5%) with an adjusted difference-in-differences of 12.5% (95% CI [5.4, 19.6], p = .001). MRP sites increased the patients with prescriptions to treat opioid use disorder from 17.0% (baseline) to 36.8% (3 years after initiation), with smaller changes observed in comparison sites (23.2% to 24.0%) and a 3-year post-initiation adjusted difference-in-differences of 19% (95% CI [8.5, 29.5], p = .000). Medications for alcohol use disorders increased in both MRP (9.0% to 26.5%) and comparison sites (11.4% to 23.1%). CONCLUSIONS: Promoting the use of medications to support recovery required complex interventions. The Advancing Recovery System Change Model, initially developed in publicly funded systems of care, was successfully adapted for commercial sector use. The model provides a framework for providers and commercial health plans to collaborate and increase patient access to medications.
PP - United States
PY - 2017
SN - 1938-4114; 1937-1888
SP - 735
EP - 744
EP - 
T1 - Promoting Adoption of Medication for Opioid and Alcohol Use Disorders Through System Change
T2 - Journal of studies on alcohol and drugs
TI - Promoting Adoption of Medication for Opioid and Alcohol Use Disorders Through System Change
U1 - Opioids & Substance Use
U2 - 28930061
VL - 78
VO - 1938-4114; 1937-1888
Y1 - 2017
Y2 - Sep
ER -